首页 | 本学科首页   官方微博 | 高级检索  
     

亚胺培南/西司他丁钠治疗重症肺炎的疗效观察
引用本文:梁永祥,黄富,吴金环. 亚胺培南/西司他丁钠治疗重症肺炎的疗效观察[J]. 岭南急诊医学杂志, 2013, 0(2): 96-97
作者姓名:梁永祥  黄富  吴金环
作者单位:广东省云浮市新兴县医院呼吸内科,527400
摘    要:目的:观察亚胺培南/西司他丁钠治疗重症肺炎的临床疗效及安全评价。方法:将2008年6月-2012年12月收治90例重症肺炎患者随机分为A、B、C三组各30例,分别使用亚胺培南/西司他丁钠1000mg静脉滴注,每8小时一次;500mg静脉滴注,每6小时一次;500mg静脉滴注,每8小时一次治疗,比较其临床疗效、细菌清除率和安全性。结果:A组、B组的临床疗效、细菌清除率和安全性均明显优于c组,P均〈0.05;但A组、B组间无显著性差异。结论:亚胺培南/西司他丁钠对重症肺炎有良好疗效,使用方法以500mg,静脉滴注,每6小时一次为最适宜。

关 键 词:亚胺培南  西司他丁钠  重症肺炎  疗效

Efficacy Observation of Severe Pneumonia Treated by Different Doses of Imipenem and Cilastatin Sodium
LIANG Yong-xiang,HUANG Fu,WU Jin-huan. Efficacy Observation of Severe Pneumonia Treated by Different Doses of Imipenem and Cilastatin Sodium[J]. Lingnan Journal of Emergency Medicine, 2013, 0(2): 96-97
Authors:LIANG Yong-xiang  HUANG Fu  WU Jin-huan
Affiliation:( Department of Respiratory Medicine, People "s Hospital of Xinxing County, Yunfu, Guangdong Province, 527400)
Abstract:Objective: To observe the efficacy and safety evaluation of severe pneumonia treated by Imipenem and Cilastatin Sodium. Method: 90 patients with severe pneumonia were randomly divided into group A, group B and group C,each group was 30 cases from Jun 2008 to Dec 2012. Group A was Imipenem and Cilastatin Sodium 1000 mg intravenously every 8 hours, Group B was treated by Imipenem and Cilastatin sodium 500 mg intravenously every 6 hours, Group C was treated by Imipenem and Cilastatin sodium 500 mg intravenously every 8 hours.The clinical efficacy, the rate of bacterial clearance and safety were compared among the three groups.Results : The clinical efficacy, the rate of bacterial clearance and safety in the group A and the group B were significantly better than those in the group C, all P〈0.05. But there were no difference between the group A and the group B. Conclusion:It has a good effect of severe pneumonia treated by Imipenem and Cilastatin Sodium and the best using method is 500mg intravenously every 6 hours.
Keywords:Imipenem and Cilastatin Sodium  severe pneumonia  efficacy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号